Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
05/21/2009 | US20090130107 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
05/21/2009 | US20090130105 Compositions that bind multiple epitopes of igf-1r |
05/21/2009 | US20090130102 Methods for humanizing antibodies and humanized antibodies made thereby |
05/21/2009 | US20090130095 Composition comprising tumor necrosis factor (CD40) specific immunoglobulin for treatment and prevention of autoimmune diseases |
05/21/2009 | US20090130093 Binding member for gm-csf receptor |
05/21/2009 | US20090130089 Anti-cd20 antibodies and methods of use |
05/21/2009 | US20090130060 Modified Vitamin K Dependent Polypeptides |
05/21/2009 | US20090130034 Re-engineered uv damage endonuclease, compositions and methods |
05/20/2009 | EP2060634A1 Structure protein of adeno-associated virus with amended antigenity, production and application thereof |
05/20/2009 | EP2060633A1 Mammalian artificial chromosomes |
05/20/2009 | EP2060630A2 PCA3, PCA3 genes, and methods of use |
05/20/2009 | EP2060628A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
05/20/2009 | EP2059606A2 Fusion peptide therapeutic compositions |
05/20/2009 | EP2059590A2 Methods for producing secreted polypeptides having biological activity |
05/20/2009 | EP2059587A2 Laccases for pulp bio-bleaching |
05/20/2009 | EP1978994A4 Bmp-7 variant compositions, methods and uses |
05/20/2009 | EP1592789B1 Administration of transposon-based vectors to reproductive organs |
05/20/2009 | EP1574521B1 Method of protecting of thiol groups in antibodies |
05/20/2009 | EP1341912B1 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
05/20/2009 | EP1163260B1 Process for partitioning of proteins |
05/20/2009 | EP0651789B2 Method for preventing zoster and alleviating varicella related post-herpetic neuralgia |
05/20/2009 | CN101437956A Humanized anti-CD20 monoclonal antibody |
05/20/2009 | CN101437953A Diacylglycerol acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous organisms |
05/20/2009 | CN101437952A High eicosapentaenoic acid producing strains of yarrowia lipolytica |
05/20/2009 | CN101437951A Docosahexaenoic acid producing strains of Yarrowia lipolytica |
05/20/2009 | CN101434982A Method for preparing vegetable seed active peptide by microbial solid state fermentation |
05/20/2009 | CN101434981A Method for preparing vegetable seed peptide with single bioactivity by microbial solid state fermentation |
05/20/2009 | CN101434980A Preparation of rice bran short peptide |
05/20/2009 | CN101434979A Method for extracting protein from cereal fine powder |
05/20/2009 | CN101434647A Epitope/peptide recognized by hla-a2402-restricted ep/cam-specific ctl and use of the same |
05/20/2009 | CN101434642A Method for preparing non-denaturation hogskin insoluble collagen powder |
05/20/2009 | CN101433722A Fusions of cytokines and tumor targeting proteins |
05/20/2009 | CN101433715A Modified chimeric polypeptides with improved pharmacokinetic properties |
05/20/2009 | CN101433714A Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
05/20/2009 | CN101433591A Method for preparing composite glycopeptide of Ficus carica |
05/20/2009 | CN100489115C Double-enzyme process for modified preparation of injection type soybean protein isolate |
05/20/2009 | CN100489114C Low-cost production for peptides |
05/20/2009 | CN100489105C Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector |
05/20/2009 | CN100489102C T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
05/20/2009 | CN100489097C Method for preparing protein using endogenetic angiogenesis inhibitive factor Arresten gene |
05/20/2009 | CN100489096C Escherichia expression system for secreting and expressing recombinant human epidermal growth factor |
05/20/2009 | CN100489095C Transformant for producing secondary metabolite modified with functional group and novel biosynthesis genes |
05/20/2009 | CN100489093C Protein and nuclear acid of antrodia camphoratu antioxidase and preparation method and use thereof |
05/20/2009 | CN100488982C Methods of preparing monoclonal antibodies binding with beta-amyloid proteins and bringing the protein configuration conversion |
05/20/2009 | CN100488563C Modified anti-EGFR antibody with reduced immunogenicity |
05/20/2009 | CN100488562C Clotting factor VII or VIIa like molecules |
05/19/2009 | US7534877 Non-M, non-O HIV-1 strains, fragments and uses |
05/19/2009 | US7534876 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
05/19/2009 | US7534870 Stable pharmaceutical composition comprising erythropoietin |
05/19/2009 | US7534869 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
05/19/2009 | US7534856 PRO19624 antibodies |
05/19/2009 | US7534608 Exposing embryonic stem cells culture to cells expressing activin receptor-like kinase (ALK) receptor, transplanting tissues into mammal, recovering insulin secreting cells; endocrine cell therapy |
05/19/2009 | US7534604 Fusion polypeptides capable of activating receptors |
05/19/2009 | US7534597 Fermenting lactic acid in kluyveromyces for use in cosmetics, pharmaceuticals, plastics and food production |
05/19/2009 | US7534594 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
05/19/2009 | US7534586 Method for producing biomass |
05/19/2009 | US7534580 Invention identifies carrier protein to which PSP94 is bound (named PSP94-binding protein), its nucleic acid and amino acid sequences; use in diagnosis and prognosis of PSP94 related disease |
05/19/2009 | US7534575 Method for detecting cancer using an antibody to Zcytor16 |
05/19/2009 | US7534572 Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue |
05/19/2009 | US7534564 Methods and compositions for polypeptide engineering |
05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
05/19/2009 | US7534444 Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
05/19/2009 | US7534436 Peptide fragments of the harp factor inhibiting angiogenesis |
05/19/2009 | US7534432 Suppressing acitivity to treat musculodegenerative disease |
05/19/2009 | US7534431 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis |
05/19/2009 | US7534430 Administering monoclonal or polyclonal antibody to treat multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease |
05/19/2009 | US7534427 Predosing with non-radiolabeled antibody not performed |
05/19/2009 | CA2345024C Modified tgf-.beta. superfamily proteins |
05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
05/14/2009 | WO2009061477A1 Production of gamma-hydroxybutyrate |
05/14/2009 | WO2009061402A2 Methods and compounds for phototransfer |
05/14/2009 | WO2009060961A1 West nile virus vaccine, and method for production thereof |
05/14/2009 | WO2009060857A1 Method for producing membrane protein |
05/14/2009 | WO2009060129A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes |
05/14/2009 | WO2009022900A3 A process to produce polypeptides from soybean |
05/14/2009 | WO2008120107A3 Glycosylation of molecules |
05/14/2009 | WO2005003299A3 Polynucleotides encoding novel guanylate binding proteins (gbp's) |
05/14/2009 | WO2004097001A3 Novel bacillus 029cel cellulase |
05/14/2009 | US20090124790 Chromatographic method and system for purifying a botulinum toxin |
05/14/2009 | US20090124780 Nanoparticle chains and Preparation Thereof |
05/14/2009 | US20090124560 Composition Containing Peptide as Active Ingredient |
05/14/2009 | US20090124541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseases |
05/14/2009 | US20090124511 Antibody complexes and methods for immunolabeling |
05/14/2009 | US20090124008 Peptides for use in culture media |
05/14/2009 | US20090123999 Nucleotide sequences invovled in plant disease resistance |
05/14/2009 | US20090123975 Feed media |
05/14/2009 | US20090123974 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
05/14/2009 | US20090123973 Methods of Making Modular Fusion Protein Expression Products |
05/14/2009 | US20090123972 Staphylococcal nuclease fusion proteins for the production of recombinant peptides |
05/14/2009 | US20090123971 Compositions of aminoacyl-tRNA synthetase and uses thereof |
05/14/2009 | US20090123970 Glycosylated mammalian ngal and use thereof |
05/14/2009 | US20090123969 Novel fluorescent protein and gene encoding the same |
05/14/2009 | US20090123968 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
05/14/2009 | US20090123967 Modified spider silk proteins |
05/14/2009 | US20090123966 Hybrid portable origin of replication plasmids |
05/14/2009 | US20090123965 Hydrolysis Process For Raw Materials From The Fishing And Slaughterhouse Industries And Tanks For Use Therein |
05/14/2009 | US20090123945 Cholinergic/serotoninergic receptor and uses thereof |
05/14/2009 | US20090123942 Electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes |
05/14/2009 | US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
05/14/2009 | US20090123911 Isolated staphylococcus dnax subunit and use thereof |